Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients

Alexandra J. van den Broeck, Marjanka K. Schmidt*, Laura J. van't Veer, Hester S. A. Oldenburg, Emiel J. Rutgers, Nicola S. Russell, Vincent T. H. B. M. Smit, Adri C. Voogd, Linetta B. Koppert, Sabine Siesling, Jan J. Jobsen, Pieter J. Westenend, Flora E. van Leeuwen, Rob A. E. M. Tollenaar

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)364-372
Number of pages9
JournalAnnals of Surgery
Volume270
Issue number2
DOIs
Publication statusPublished - Aug 2019

Keywords

  • BRCA1
  • BRCA2
  • breast cancer
  • breast-conserving therapy
  • mastectomy
  • prognosis
  • survival
  • 20-YEAR FOLLOW-UP
  • TUMOR RECURRENCE
  • SURVIVAL
  • RADIOTHERAPY
  • RISK
  • WOMEN
  • CONSERVATION
  • RADIATION
  • 10-YEAR
  • SURGERY

Cite this

van den Broeck, A. J., Schmidt, M. K., van't Veer, L. J., Oldenburg, H. S. A., Rutgers, E. J., Russell, N. S., Smit, V. T. H. B. M., Voogd, A. C., Koppert, L. B., Siesling, S., Jobsen, J. J., Westenend, P. J., van Leeuwen, F. E., & Tollenaar, R. A. E. M. (2019). Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients. Annals of Surgery, 270(2), 364-372. https://doi.org/10.1097/SLA.0000000000002804